October 6, 2023 • 8 mins read TrialX Congratulates Dr. Drew Weissman, Dr. Katalin Karikó and the University of Pennsylvania! – The Nobel Prize Winning mRNA Covid Vaccine Story The Nobel Prize winning work of the mRNA covid vaccine, has an interesting story that began three decades ago, with a little-known scientist duo who…
October 19, 2020 • 2 mins read CureTalks Launches New Talk Series on Contribution of Small Biotech Companies Towards Drug Development of Orphan Diseases CureTalks launches its new series featuring biotech companies at the cutting edge of innovation and breakthrough research with the purpose of bringing their contributions…
June 1, 2020 • 4 mins read Hydroxychloroquine, when Politics and Science Intersect Hydroxychloroquine, When Politics And Science Intersect
April 29, 2020 • 8 mins read COVID-19 Clinical Trial Recruitment supported through iConnect TrialX assists academic medical centers in recruitment for clinical research by offering iConnect, a patient friendly, centralized trial listing and recruitment platform. We proudly…
April 27, 2018 • 3 mins read Exclusive Interview with CAR T Cell Therapy Pioneer Dr Carl June – Time’s top 100 Most Influential People in the World Time magazine named CAR-T cell therapy pioneer Dr Carl June of University of Pennsylvania in their 2018 TIME 100 annual list of the 100…
February 4, 2018 • 8 mins read [Infographic] ASCO Names CAR-T Cell Immunotherapy Clinical Cancer Advance of the Year 2017 CAR T-Cell Immunotherapy has been named Advance of the Year in Annual ASCO Report. Cancer experts looking back over the past 12 months have…
November 14, 2017 • 6 mins read CAR-T Cell Therapy Clinical Trials – Promising Advancement in Medicine Two radically new gene based immunotherapies were approved by the FDA this year – Kymriah followed by Yescarta – in August and October, respectively.…
February 6, 2010 • 2 mins read Cure Mania grips TrialX! Launching Cure Talk, Cure Bytes and Curepedia. As the Superbowl mania grips the football fans across the country this weekend, we at TrialX have been gripped with the launch of new…